Cowen Prime Advisors LLC - CYTOSORBENTS CORP ownership

CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 93 filers reported holding CYTOSORBENTS CORP in Q4 2021. The put-call ratio across all filers is 0.50 and the average weighting 0.0%.

Quarter-by-quarter ownership
Cowen Prime Advisors LLC ownership history of CYTOSORBENTS CORP
ValueSharesWeighting
Q2 2023$151,861
+134290.3%
42,301
-8.1%
0.05%
+15.6%
Q1 2023$113
+76.6%
46,050
+11.8%
0.04%
+73.1%
Q4 2022$64
-99.9%
41,200
-2.4%
0.03%
-21.2%
Q3 2022$57,000
-38.0%
42,2000.0%0.03%
-36.5%
Q2 2022$92,000
+84.0%
42,200
+170.5%
0.05%
+147.6%
Q1 2022$50,000
+212.5%
15,600
+316.0%
0.02%
+320.0%
Q4 2021$16,000
+60.0%
3,750
+212.5%
0.01%
+25.0%
Q3 2021$10,000
-89.1%
1,200
-97.2%
0.00%
-92.3%
Q2 2020$92,00042,2000.05%
Other shareholders
CYTOSORBENTS CORP shareholders Q4 2021
NameSharesValueWeighting ↓
Sargent Investment Group, LLC 692,738$5,524,0002.01%
Skylands Capital, LLC 1,421,700$11,345,0001.89%
SECTORAL ASSET MANAGEMENT INC 1,629,989$12,999,0001.12%
Winning Points Advisors, LLC 286,200$1,142,990,0000.97%
Redmile Group, LLC 2,101,131$16,757,0000.31%
Granahan Investment Management 632,035$5,040,0000.17%
Avenir Corp 190,240$1,517,0000.16%
Seelaus Asset Management LLC 20,000$160,0000.13%
Olympiad Research LP 17,816$142,0000.07%
HighMark Wealth Management LLC 10,000$80,0000.07%
View complete list of CYTOSORBENTS CORP shareholders